Health secretary wants NHS to rollout genetic tests to detect diseases

Matt Hancock claims technology is ‘a game-changer’ but critics raise racial bias and ‘fatalism’ concernsThe health secretary is calling for predictive genetic tests for common cancers and heart disease to be rolled out on the NHS without delay.Matt Hancock, speaking at the Royal Society on Wednesday, revealed he recently took a commercial genetic test that showed he is at heightened risk of developing prostate cancer, saying he was shocked by the result. Hancock called for a national debate about the ethical issues around testing for diseases, some of which could not readily be treated.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Genetics Matt Hancock NHS Science UK news Race Health Source Type: news

Related Links:

Beyond its effects on the body, medical care can be a balm for the mind. Extensive treatment can feel like a promise that doctors have done everything possible. But that perceived security can come at a high price. As health costs soar, patients are emptying their pockets for care that may not make them healthier, research suggests. Last year, a 5,000-person trial showed that for patients with chronic but stable heart disease, surgical procedures such as stenting and bypass did not reduce the risk of heart attack or death more than lifestyle interventions and medication. Even patients with extensive damage did not, on aver...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Surgery Source Type: news
Over the last few decades, the death rate from cancer dropped by 29% in the U.S., according to the latest data from the American Cancer Society (ACS). That, the ACS’s new study estimates, saved 2.9 million lives from 1991 to 2017, largely owing to declines in mortality from the four leading cancer types: lung, breast, prostate and colon. From 2016 to 2017—the latest year for which data are available—the overall cancer death rate declined by 2.2%, the largest single-year reduction ever recorded. These new figures were reported in a study published in CA: A Cancer Journal for Clinicians. The declines are a...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized Cancer Source Type: news
(Reuters Health) - Many cancer patients and survivors die from heart disease rather than from their tumors, especially if they have certain malignancies like breast and prostate cancer, a U.S. study suggests.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
(Intermountain Medical Center) Intermountain research team identified 87 patients who were part of the Intermountain INSPIRE Registry and had developed prostate cancer. These patients were also tested for plasma levels of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), which are two common omega-3 fatty acids.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
In this study, we used large-scale electronic health records data from multiple linked UK databases to address these evidence gaps.MethodsFor this population-based cohort study, we used linked primary care, hospital, and cancer registry data from the UK Clinical Practice Research Datalink to identify cohorts of survivors of the 20 most common cancers who were 18 years or older and alive 12 months after diagnosis and controls without history of cancer, matched for age, sex, and general practice. We compared risks for a range of cardiovascular disease outcomes using crude and adjusted Cox models. We fitted interactions to in...
Source: The Lancet - Category: General Medicine Source Type: research
TUESDAY, Aug. 13, 2019 -- When men have both advanced prostate cancer and heart disease, treatment may pose a dilemma: Newer hormonal therapies that can slow the cancer down might also be risky for their hearts, a new study finds. Once prostate...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Abstract Lack of insulin or insulin resistance (IR) plays a central role in diabetes mellitus and makes diabetics prone to acute ischemic heart disease (AIHD). It has likewise been found that many cancer patients, including prostate cancer patients die of AIHD. Previously it has been delineated from our laboratory that dermcidin could induce anomalous platelet aggregation in AIHD and also impaired nitric oxide and insulin activity and furthermore dermcidin was also found in a few types of cancer patients. To determine the role of this protein in prostatic malignancy a retrospective case-control study was conducted...
Source: Bioscience Reports - Category: Biomedical Science Authors: Tags: Biosci Rep Source Type: research
Did you know that adding color to your meals will help you live a longer, healthier life? Colorful fruits and vegetables can paint a beautiful picture of health because they contain phytonutrients, compounds that give plants their rich colors as well as their distinctive tastes and aromas. Phytonutrients also strengthen a plant’s immune system. They protect the plant from threats in their natural environment such as disease and excessive sun. When humans eat plant foods, phytonutrients protect us from chronic diseases. Phytonutrients have potent anti-cancer and anti-heart disease effects. And epidemiological research...
Source: Harvard Health Blog - Category: Consumer Health News Authors: Tags: Health Healthy Eating Source Type: blogs
CONCLUSIONS: Patient-reported pretreatment sexual function and comorbidities enables stratification and prediction of erectile function. EPIC subset questions with baseline comorbidities may potentially serve as a quick and practical clinical tool for predicting sexual survivorship. PMID: 31005217 [PubMed - in process]
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - Category: Radiology Authors: Tags: Radiother Oncol Source Type: research
Conclusions and Perspectives In this review, we have discussed important milestones from the early description of “Serum-sickness” as being due to antibodies directed against Neu5Gc epitopes all the way to the present-day therapeutic implications of these antibodies in cancer therapy. Some of these milestones have been represented in a concise timeline (Figure 6). While the “Xenosialitis” hypothesis is well-supported in the human-like mouse models, it has yet to be conclusively proven in humans. It remains to be seen if “Xenosialitis” plays a role in other uniquely-human diseases. FI...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Genetics | Heart | Heart Disease | Medical Ethics | Prostate Cancer | Science